US, Philippines deploy anti-ship missile system in Batanes near Taiwan for war games
China's railway hit new single-day passenger record on May Day
Trump auto tariff hike could cost Germany nearly $18 billion in output, institute says
NATO: working with US to understand details of troop reduction in Germany
Alex Zanardi, auto racing champion-turned-Paralympian, dies at 59 after life-altering accidents
Reclusive Turkmenistan shows signs of cautiously opening up
Business|Health|Science|Technology|US
US FDA approves Pfizer, Arvinas' breast cancer drug
The U.S.
May 01, 2026Pfizer
Business|Economy|Health
Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says
Pfizer's Chief Strategy and Innovation Officer, Andrew Baum, is transitioning to a new role and will eventually leave the company as part of the U.S. drugmaker's strategic
April 21, 2026
Health|Science|Technology|World
FDA intends to put its most serious warning on Covid vaccines, sources say
FDA intends to put its most serious warning on Covid vaccines, sources say
December 12, 2025
Business|Economy|Health|Science|Technology
Moderna takes $1.5 billion loan, expects 10% revenue growth next year
Moderna said on Thursday it secured a five-year loan of $1.5 billion from Ares Management, as it targets up to 10% revenue growth next year.
November 20, 2025
Business|Economy|Finance|Health|Stock Markets
Activist Starboard sells Pfizer stake after pushing for changes
Activist investor Starboard Value has liquidated its position in Pfizer, according to a regulatory filing on Friday, ending its push for changes aimed at
November 14, 2025
Business|Finance|Health|Science|World
Pfizer's former R&D chief Dolsten pulls out of Novo Nordisk board race
Mikael Dolsten, Pfizer's former research and development chief, has withdrawn his candidacy for Novo Nordisk's board, citing personal reasons, the Danish drugmaker said on Thursday.
November 13, 2025
Business|Economy|Health|Science|Technology
Pfizer slashes stake in COVID vaccine partner BioNTech
Pfizer Inc said on Thursday it sold a part of its stake in German drugmaker BioNTech SE, more than five years after both firms formed an alliance that yielded a vaccine to combat the deadly
November 13, 2025
Business|Economy|Health|World
'Not been pretty': Novo Nordisk faces rare shareholder rebuke over board shake-up
Novo Nordisk faces a shareholder backlash on Friday as the Danish drugmaker's minority investors prepare a protest vote against
November 13, 2025
Business|Economy|Health|Science|Technology
Pfizer completes up to $10 billion acquisition of Metsera
Pfizer on Thursday closed its up to $10 billion acquisition of Metsera after winning shareholder approval, gaining a foothold in the fast-growing obesity
November 13, 2025
Business|Europe|Health|Science|Technology
BioNTech says collaboration with Pfizer remains unchanged
BioNTech said on Thursday that its collaboration with Pfizer has not changed, when asked to comment on a report that Pfizer is looking to sell its stake in the German biotech firm
November 13, 2025
Business|Economy|Health
Novo Nordisk CEO signals new appetite for risk in obesity deals
When Novo Nordisk CEO Mike Doustdar learned in late September that Metsera had accepted a $7.3 billion rival bid from Pfizer, he was not
November 12, 2025